TNYA Tenaya Therapeutics Inc
Company Analysis
Latest News
🔴 Tenaya Therapeutics is trading 5.7% down today after Q2 revenue miss and larger-than-expected loss
Tenaya Therapeutics is trading 5.7% down at $0.74 after its August 5, 2026, second-quarter results missed revenue and loss expectations. - Collaboration...
Tenaya Therapeutics' second quarter loss widens on impairment charge, missing estimates, but provides positive clinical updates.
Tenaya Therapeutics reported second quarter collaboration revenue of $1.11 million and a net loss of $0.20 per share, missing consensus estimates of $10.0...
🟢 Tenaya Therapeutics is trading 5% up today ahead of its Q2 earnings report
Tenaya Therapeutics is trading 5% up at $0.76 as investors position ahead of its Q2 2026 earnings report. • The company is scheduled to release its quarterly...
Tenaya Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Tenaya Therapeutics Inc is expected to report a Q2 2026 consensus loss of $0.08 per share on revenue of $10.0 million, with its current stock price of $0.75...
🔴 Tenaya Therapeutics is trading 5.3% down today on Nasdaq listing pressure and dilution concerns
Tenaya Therapeutics is trading 5.3% down today at $0.79 as investors react to ongoing Nasdaq minimum bid price non-compliance and recent dilution from a $60...
🔴 Tenaya Therapeutics is trading 5.8% down today amid biotech weakness and sector-wide profit-taking
Tenaya Therapeutics is trading at $0.82 (-5.78%) as the stock moves lower alongside a weaker biotech tape and broader risk-off sentiment. • The decline...
🔴 Tenaya Therapeutics is trading 8.1% down today amid broader market weakness and speculative volatility
Tenaya Therapeutics is trading at $0.80 (-8.05%) in pre-market, reflecting normal volatility for a speculative biotech stock following a volatile run in early...
🔴 Tenaya Therapeutics is trading 6.5% down today, extending a multi-day pullback
Tenaya Therapeutics is trading at $0.80 (down 6.5%), extending a multi-day pullback following a volatile rally earlier in July. • The decline appears to be...
🟢 Tenaya Therapeutics is trading 5.8% up today, rebounding from a recent pullback
Tenaya Therapeutics is trading 5.8% up today at $0.93, rebounding from yesterday’s pullback and continuing its recent volatile pattern. • The move occurs...
🔴 TNYA is trading 5.1% down today amid broader market weakness and profit-taking
TNYA is trading at $0.87 (-5.09%) today, appearing to give back gains from a previous rebound amid broader market weakness and a lack of fresh company-specific...
🟢 TNYA is trading 6.1% up today as it extends recent positive momentum
TNYA is trading at $0.92 (6.1% up) as it extends a short-term uptrend despite a lack of fresh company-specific news or analyst actions today. • The move...
🟢 TNYA is trading 5.9% up today with no clear company-specific catalyst identified
TNYA is trading at 5.9% up now at $0.79 on light news flow, extending its recent multi-day upward drift from the low-$0.70s. With no fresh company...
🟢 TNYA is trading 5% up today with no clear news catalyst
TNYA is trading 5% up today at $0.75 in pre-market, recovering modestly after recent weakness in the sub-$1 range. • The move appears driven by light...
🔴 TNYA is trading 7.1% down today on continued risk-off weakness
TNYA is trading at $0.65 (down 7.1%), extending last week’s volatility and breaking below the $0.70 level. • The move appears to be a continuation of recent...
🟢 Tenaya Therapeutics Inc is trading 5.2% up today in a modest rebound from recent weakness
Tenaya Therapeutics Inc is trading 5.2% up at $0.71 today, appearing to stage a modest rebound following recent downward pressure. • The stock's gain follows...
🟢 Tenaya Therapeutics Inc is trading 5.2% up today amid broad risk-on rally
Tenaya Therapeutics Inc is trading 5.2% up at $0.75 in pre-market, rebounding from a recent downtrend as the stock participates in a broader risk-on market...